The Healthcare Edge — March 7, 2026

DSO consolidation just shifted into a higher gear: MB2 Dental crossed 800 practices, Aspen Dental swallowed ClearChoice's implant empire, and Western Dental pushed east—all in the same week. MB2 hit the 800-practice milestone, making it the nation's largest dental partnership organization by location count. Aspen Dental acquired ClearChoice Management Services, combining 1,000+ general dentistry offices with ~100 implant centers to create end-to-end patient capture from cleaning to full-arch restoration. Western Dental acquired Mid-Atlantic Dental Partners, vaulting from its California base into East Coast markets. The Beekman Group exited Riccobene Family Dentistry in the Southeast, validating the PE roll-up-and-sell playbook. Straine Dental added a practice in Georgetown, Texas, the Austin corridor's hottest growth zip code. Independent practice owners watching this wave: the buyers are still buying, but the window where quality practices command premium multiples won't stay open forever.

The dental AI arms race is no longer hypothetical. VideaHealth and Aspen Dental launched one of the largest AI deployments in dentistry, rolling out AI-powered radiograph analysis across Aspen's entire 1,000+ office network. Great Expressions Dental Centers selected VideaAI as its enterprise platform—another 300 offices standardizing on the same AI. Planet DDS unveiled DentalOS AI Agents to automate scheduling, insurance verification, and treatment follow-up. DentScribe launched an agentic AI platform that converts SOAP notes into chairside checklists and flags missed production. The pattern is clear: diagnostic AI is now table stakes, and the frontier has moved to operational automation—AI that runs the business, not just reads the X-rays.

58% of dental practices have committed to RCM automation, per a new 2026 industry report—crossing the tipping point from early adoption to mainstream. Archy raised $10 million to build practice management tools that let independent dentists compete with DSO-level operational efficiency. Henry Schein opened a dental-medical integration training center in Southlake, Texas, betting that the wall between dental and medical practice is coming down.

Federal health agencies are bleeding talent. FDA vaccines chief Vinay Prasad is leaving the agency for the second time, creating a leadership vacuum at the center responsible for vaccine and biologic approvals. NIH's workforce has shrunk to its smallest in decades—cancer immunotherapy pioneers, infectious disease researchers, and tobacco prevention scientists among the departed. The downstream cost: fewer clinical breakthroughs, slower evidence pipelines, and a generation of physician-scientists redirected away from public research.

Hospitals are urging regulators to block Eli Lilly and Novo Nordisk from imposing expanded data requirements on 340B drug discount participants. The AHA calls the demands unlawful; manufacturers call 340B bloated. Billions in safety-net funding hang on the outcome. Mayo Clinic reported higher net revenue for 2025, powered by volume gains across outpatient, inpatient, and surgical lines—proof that patient demand rewards systems with strong brands and operational discipline.

The DSOs are consolidating, the AI vendors are embedding, and the federal agencies are hollowing out. The organizations that move now—on technology, on partnerships, on talent—will set the terms for the next decade of American healthcare.

📊 DSO Deal Tracker — 3,200+ dental & healthcare M&A transactions tracked since 2016. Filter by year, state, acquirer type, and sector. Updated daily.

Built by the team behind Praxis AI — intelligence for modern healthcare.